Effective December 28, 2021, ZIOPHARM Oncology, Inc. as borrower, entered into a First Amendment to the Loan and Security Agreement dated August 6, 2021, by and among the Company, the lenders party thereto and Silicon Valley Bank, as administrative agent and collateral agent The Amendment principally makes the below modifications.